| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Head Of R&D | Head Of Research And Developme | Head Of Research And Developme +1 more
1 company
Blackman Samuel C. is a Head Of R&D at Day One Biopharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $22.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2022 | DAWN Day One Biopharmaceuticals, Inc. | Chief Medical Officer | Sell | 10,000 | $16.88 | $168,810.00 | -0.8% | +28.6% | -18.8% | |
| Jul 1, 2022 | DAWN Day One Biopharmaceuticals, Inc. | Chief Medical Officer | Sell | 10,000 | $18.72 | $187,158.09 | -0.3% | -1.7% | -40.2% | |
| Jun 15, 2022 | DAWN Day One Biopharmaceuticals, Inc. | Chief Medical Officer | Sell | 50,000 | $16.26 | $813,155.00 | -3.7% | +55.7% | -13.8% | |
| Jan 3, 2022 | DAWN Day One Biopharmaceuticals, Inc. | Chief Medical Officer | Sell | 10,000 | $17.10 | $171,017.86 | -0.4% | -38.9% | +15.9% | |
| Dec 1, 2021 | DAWN Day One Biopharmaceuticals, Inc. | Chief Medical Officer | Sell | 10,000 | $17.22 | $172,242.16 | -0.2% | -18.9% | +29.2% |